Search Results - Bermejo, B.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast C... by Baselga, J., Zamagni, C., Gómez, P., Bermejo, B., Nagai, S., Melichar, B., Chan, Arlene, Mángel, L., Bergh, J., Costa, F., Gómez, H., Gradishar, W., Hudis, C., Rapoport, B., Roché, H., Patricia, M., Huang, L., Meinhardt, G., Zhang, J., Schwartzberg, L.

    Published 2017
    Get full text
  2. 2
    Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial

    Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvan... by Gianni, L., Mansutti, M., Anton, A., Calvo, L., Bisagni, G., Bermejo, B., Semiglazov, V., Thill, M., Chacon, J., Chan, Arlene, Morales, S., Alvarez, I., Plazaola, A., Zambetti, M., Redfern, A., Dittrich, C., Dent, R., Magazzu, D., De Fato, R., Valagussa, P., Tusquets, I.

    Published 2018
    Get full text

Search Tools: